Tadalafil and Metoprolol Interaction

Drug interaction information between Tadalafil and Metoprolol.

Tadalafil and Metoprolol have a documented minor interaction in FDA labeling.

FDA drug labeling documents a minor-severity interaction between Tadalafil and Metoprolol. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Tadalafil

PDE5 Inhibitor

Drug B

Metoprolol

Beta-Blocker

How They Interact

These drugs both work to lower blood pressure, which can lead to a combined effect that lowers pressure more than intended.

FDA Label Information

Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).

Metoprolol Also Interacts With

View all Metoprolol interactions →

Frequently Asked Questions

What SPL severity band is on file for Tadalafil + Metoprolol?

Compiled FDA labeling labels this pair minor. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Tadalafil has 25 labeled pairs on file vs Metoprolol's 18. In the minor band specifically: Tadalafil has 22 (also Amlodipine, Tamsulosin, Aspirin, Warfarin); Metoprolol has 14 (also Fluoxetine, Paroxetine, Propafenone, Epinephrine).

What mechanism field is on file for Tadalafil and Metoprolol?

These drugs both work to lower blood pressure, which can lead to a combined effect that lowers pressure more than intended.

Tadalafil's labeled portfolio outnumbers Metoprolol

SPL source-record counts only. This page's band is minor · classes on file: Tadalafil (PDE5 Inhibitor); Metoprolol (Beta-Blocker).

Tadalafil

1 major · 2 moderate · 22 minor · 25 total

Metoprolol

1 major · 3 moderate · 14 minor · 18 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.